subject: UMLS:C3658202

subject_name: Androxal

object_name: type 2 diabetes mellitus


subject: UMLS:C5577555

subject_name: Opdualag

object_name: mucosal melanoma

tested_intervention: yes


subject: CHEBI:78884

object_name: Chronic blepharitis

tested_intervention: unsure


subject: UMLS:C0076129


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: ulcerative colitis


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: pulmonary tuberculosis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: osteoarthritis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Cirrhosis


subject: CHEBI:89324

object_name: liver cirrhosis


subject: CHEBI:89324

object_name: liver carcinoma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C0004886

subject_name: BCG Vaccine

object_name: Bladder cancer recurrent


subject: UMLS:C0004886

object_name: Recurrent tumor


subject: UMLS:C0004886

object_name: non-invasive bladder urothelial carcinoma


subject: UMLS:C0004886

object_name: Urothelial carcinoma recurrent


subject: CHEBI:90620

subject_name: Vatalanib

object_name: Childhood Breast Carcinoma


subject: CHEBI:90620

object_name: breast carcinoma


subject: CHEBI:90620

object_name: breast cancer


subject: CHEBI:90620

object_name: cervical cancer


subject: CHEBI:90620

object_name: cervical carcinoma


subject: CHEBI:90620

object_name: endometrial cancer


subject: CHEBI:90620

object_name: uterine corpus cancer


subject: CHEBI:90620

object_name: endometrial carcinoma


subject: CHEBI:90620

object_name: peritoneum cancer


subject: CHEBI:90620

object_name: ovarian cancer


subject: CHEBI:90620

object_name: ovarian neoplasm


subject: CHEBI:90620

object_name: ovarian carcinoma


subject: CHEBI:90620

object_name: fallopian tube carcinoma


subject: CHEBI:90620

object_name: fallopian tube cancer


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: CHEBI:42567

subject_name: Fisetin

object_name: Coronavinae infectious disease


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C2346820


subject: UMLS:C4684842

subject_name: Etigilimab


subject: UMLS:C4684842

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4684842

object_name: Embolism, Tumor


subject: UMLS:C4684842

object_name: Neoplasm Metastasis


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Complications of Diabetes Mellitus


subject: UNII:KV1M7Q3CBP

object_name: Refractory Leukemia


subject: UMLS:C4744685


subject: UMLS:C4744685

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C4744685

object_name: acute lymphoblastic leukemia


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C0733796

subject_name: Gastrografin

object_name: gastroschisis


subject: UMLS:C0733796

object_name: intestinal obstruction


subject: UMLS:C0733796

object_name: Dysmorphism


subject: UMLS:C0733796

object_name: Fetal anomaly


subject: CHEBI:132967

subject_name: Elbasvir

object_name: Disorder of transplanted kidney


subject: CHEBI:132967

object_name: Chronic uremia


subject: CHEMBL.COMPOUND:CHEMBL4298004

subject_name: VOPRATELIMAB

object_name: cancer


subject: CHEMBL.COMPOUND:CHEMBL4298004

object_name: neoplasm


subject: UMLS:C4329331

subject_name: Vopratelimab


subject: UMLS:C4329331


subject: CHEBI:350546

object_name: generalized anxiety disorder


subject: CHEBI:28790

subject_name: Serotonin


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: immune system disorder


subject: UNII:AIN96D6SGL


subject: PR:000015223

subject_name: solute carrier organic anion transporter family member 1B1


subject: UMLS:C3896734

object_name: Advanced Gastric Adenocarcinoma


subject: UMLS:C2351132

subject_name: Acetaminophen / Codeine

object_name: acute pain due to trauma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: congenital heart disease


subject: CHEBI:88316

subject_name: Nefopam

object_name: Shivering


subject: CHEBI:34435

subject_name: p-Toluenesulfonamide

object_name: lung cancer


subject: CHEBI:34435

object_name: lung neoplasm


subject: CHEBI:34435

object_name: lung carcinoma


subject: CHEBI:28498

subject_name: Acadesine

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: leukemia


subject: UNII:15C2VL427D

object_name: childhood leukemia


subject: UMLS:C5198356

subject_name: PEGylated carboxyhemoglobin bovine

object_name: Leg Ulcer


subject: UMLS:C5198792

subject_name: Sanguinate


subject: UNII:7IK8Z952OK

subject_name: Plecanatide

object_name: irritable bowel syndrome with constipation


subject: CHEBI:27777

subject_name: Acetohydroxamic acid

object_name: urea cycle disorder


subject: UMLS:C0718238

subject_name: Actidose-Aqua

object_name: malaria


subject: UMLS:C0718238

object_name: Severe Malaria


subject: PUBCHEM.COMPOUND:52918381

object_name: Infection


subject: PUBCHEM.COMPOUND:52918381

object_name: infectious disease


subject: PUBCHEM.COMPOUND:52918381

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:52918381

object_name: bacterial infectious disease


subject: UMLS:C3884827


subject: UMLS:C3884827


subject: UMLS:C3884827


subject: UMLS:C3884827


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Nasal Polyp


subject: CHEBI:7862

subject_name: Oxymetazoline


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:6970

subject_name: Mometasone

object_name: psoriasis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic osteosarcoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:6129

subject_name: Ketorolac

object_name: pancreatic neoplasm


subject: CHEBI:6129

object_name: exocrine pancreatic carcinoma


subject: CHEBI:6129

object_name: malignant pancreatic neoplasm


subject: CHEBI:6129

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Abnormal bleeding


subject: PUBCHEM.COMPOUND:13559282

object_name: Menorrhagia


subject: CHEBI:71025

subject_name: ulipristal


subject: UNII:E8R04MBQ04

object_name: Plasma cell myeloma refractory


subject: UMLS:C2830202


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: non-Hodgkin lymphoma


subject: CHEBI:231605

object_name: plasma cell myeloma


subject: CHEBI:231605

object_name: T-Cell Lymphoma


subject: CHEBI:72690

subject_name: Pomalidomide


subject: UMLS:C1622916

subject_name: ISOPROPYL ALCOHOL 70%

object_name: Propionibacterium infection


subject: CHEBI:17824

subject_name: isopropanol


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Inflammatory Response


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:DLE8519RWM

object_name: Stage II Bladder Cancer AJCC v8


subject: UNII:DLE8519RWM

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: obstructive sleep apnea syndrome


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:3223

subject_name: Buspirone

object_name: Acute Ischemic Stroke


subject: CHEBI:3223

object_name: Ischemic stroke


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:6754

subject_name: Meperidine


subject: CHEBI:6754


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Pregnant


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: psychosocial effects of cancer and its treatment


subject: CHEBI:4026

object_name: cognitive/functional effects


subject: CHEBI:4026

object_name: malnutrition


subject: CHEBI:4026

object_name: Depressed mood


subject: CHEBI:4026

object_name: Cancer patients and suicide and depression


subject: CHEBI:4026

object_name: Depressed - symptom


subject: CHEBI:4026

object_name: Depression, CTCAE


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:64816

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:91872


subject: CHEBI:28748


subject: CHEBI:83766

subject_name: Olaparib

object_name: leiomyosarcoma of the corpus uteri


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: traumatic encephalopathy


subject: CHEBI:64321

object_name: traumatic brain injury


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Fracture at wrist and/or hand level


subject: CHEBI:60802

object_name: Injuries to the wrist, hand and fingers (S60-S69)


subject: CHEBI:60802

object_name: Rupture of tendon of wrist and hand


subject: CHEBI:60802

object_name: carpal tunnel syndrome 1


subject: CHEBI:60802

object_name: carpal tunnel syndrome


subject: CHEBI:60802

object_name: Myxoid cyst


subject: UMLS:C4085974

object_name: Neoplasms by Histologic Type


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4763426

subject_name: Tuparstobart

object_name: melanoma


subject: UNII:79O7855J4G

subject_name: Sepetaprost

object_name: Ocular hypertension


subject: UNII:79O7855J4G

object_name: OPTN-related open angle glaucoma


subject: UNII:79O7855J4G

object_name: open-angle glaucoma


subject: UMLS:C5417784

object_name: carcinoma of esophagus


subject: UMLS:C5417784

object_name: esophageal cancer


subject: UMLS:C5417784

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5417784

object_name: neoplasm of esophagus


subject: CHEBI:16796

subject_name: Melatonin

object_name: Impacted third molar tooth


subject: MESH:C000707247

object_name: chronic kidney disease


subject: MESH:C000707247

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:322ZMR6920

object_name: butyrylcholinesterase deficiency


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Global Relapse in Viscera


subject: CHEBI:52717

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:52717

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:52717

object_name: Global Relapse


subject: CHEBI:52717

object_name: Global Relapse in Skin


subject: CHEBI:52717

object_name: Global Relapse in Blood


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Acne inversa


subject: UNII:UC95NQ339C

object_name: Hyperhidrosis, CTCAE


subject: UNII:UC95NQ339C

object_name: Hyperhidrosis


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: RXCUI:1940699

subject_name: glecaprevir / pibrentasvir Oral Product

object_name: end stage renal failure


subject: RXCUI:1940699

object_name: Chronic uremia


subject: CHEBI:28870

object_name: High Risk Neuroblastoma


subject: UMLS:C2733644

subject_name: Black Seed Oil

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C2733644

object_name: metabolic syndrome X


subject: UNII:6B7TYB2MJX

subject_name: Cudetaxestat


subject: UNII:6B7TYB2MJX

object_name: Chronic liver disease


subject: UMLS:C5853745


subject: UMLS:C5853745


subject: PUBCHEM.COMPOUND:11422859

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Childhood Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:11422859

object_name: anaplastic large cell lymphoma


subject: CHEBI:29312

subject_name: sulfanyl

object_name: dry eye syndrome


subject: CHEBI:29312

object_name: Dry Eye, CTCAE


subject: CHEBI:29312

object_name: Dryness of eye


subject: CHEBI:73651

subject_name: Ser-His


subject: CHEBI:73651


subject: CHEBI:73651


subject: UniProtKB:P55248

subject_name: SH_RAT Putative protein SH (sprot)


subject: UniProtKB:P55248


subject: UniProtKB:P55248


subject: CHEBI:230801

subject_name: Morinidazole

object_name: pelvic inflammatory disease


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: Cerebral venous thrombosis


subject: CHEBI:15365

subject_name: Aspirin

object_name: Asymmetrical growth retardation


subject: CHEBI:3207

subject_name: Budesonide

object_name: Coronavinae infectious disease


subject: CHEBI:91872

object_name: Small cell lung cancer recurrent


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C2347570

object_name: liver cancer


subject: UMLS:C2347570

object_name: liver neoplasm


subject: UMLS:C2347570

object_name: Adult Liver Carcinoma


subject: UMLS:C2347570

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:57320831

subject_name: Urodilatin

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:57320831

object_name: Hepatic ascites


subject: GTOPDB:8446

subject_name: ularitide


subject: GTOPDB:8446


subject: UMLS:C0077910

subject_name: Ularitide


subject: UMLS:C0077910


subject: UMLS:C5557271

subject_name: Nicotine Oral Pouch

object_name: Alcohol-Related Carcinoma


subject: UMLS:C4548561

object_name: hemolytic anemia


subject: UMLS:C1831911

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: Musculoskeletal Pain


subject: UMLS:C5446645

subject_name: Sodium Thiosulfate Formulation DB-020

object_name: ototoxicity


subject: UNII:464OXX39Y6

subject_name: Dinalbuphine sebacate

object_name: Caesarean section


subject: UNII:464OXX39Y6

object_name: pain agnosia


subject: UNII:464OXX39Y6

object_name: Pain insensitivity


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: Chemotherapy-induced nausea and vomiting


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: brain glioma


subject: CHEBI:64073

object_name: diastolic heart failure


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: age-related macular degeneration


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:233362

subject_name: Abemaciclib


subject: CHEBI:233362

object_name: ERK Family Gene Mutation


subject: CHEBI:233362

object_name: RAF1 Gene Mutation


subject: CHEBI:233362

object_name: MAP2K1 Gene Mutation


subject: CHEBI:233362

object_name: MAP2K2 Gene Mutation


subject: UNII:V0Q46LFE6F


subject: UNII:V0Q46LFE6F


subject: UNII:V0Q46LFE6F


subject: UNII:V0Q46LFE6F


subject: UNII:V0Q46LFE6F


subject: UNII:V0Q46LFE6F

object_name: Disseminated Malignant Neoplasm


subject: UNII:V0Q46LFE6F

object_name: Embolism, Tumor


subject: UNII:V0Q46LFE6F

object_name: cancer


subject: UNII:V0Q46LFE6F

object_name: neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Effects of high altitude


subject: CHEBI:177609

subject_name: Tariquidar


subject: CHEBI:177609


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Acute schizophrenia


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: Childhood Breast Carcinoma


subject: UMLS:C4086499

object_name: breast carcinoma


subject: UMLS:C4086499

object_name: breast cancer


subject: CHEBI:125400

subject_name: actinomycin D

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:27666

subject_name: Dactinomycin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: acute lymphoblastic leukemia


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: metastatic melanoma


subject: CHEBI:91397

object_name: Unresectable Melanoma


subject: CHEBI:91397

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: CHEBI:91397

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: CHEBI:91397

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:91397

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:91397

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C5418031

subject_name: Anti-HER2-DM1 Antibody-drug Conjugate GQ1001

object_name: HER2 positive breast carcinoma


subject: UMLS:C5418031

object_name: HER2 positive biliary tract cancer


subject: PUBCHEM.COMPOUND:126756

object_name: epilepsy


subject: CHEBI:34992

subject_name: Talampanel


subject: CHEBI:53762

object_name: obstructive sleep apnea syndrome


subject: CHEBI:32315

subject_name: Zopiclone


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Immune Tolerance


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: GTOPDB:8002

subject_name: bavituximab

object_name: non-small cell squamous lung carcinoma


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C1329986

subject_name: BUPIVACAINE/FENTANYL

object_name: pain agnosia


subject: UMLS:C1329986

object_name: Pain insensitivity


subject: UMLS:C1329986

object_name: Labor Pain


subject: UMLS:C2975721

object_name: neuroendocrine neoplasm


subject: UMLS:C2975721

object_name: neuroendocrine carcinoma


subject: UMLS:C2975721

object_name: carcinoid tumor


subject: UMLS:C2975721

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Vocal cord dysfunction


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Posttransplant diabetes mellitus


subject: PUBCHEM.COMPOUND:6320532

subject_name: Cenicriviroc

object_name: Hepatic impairment


subject: MESH:C546310

subject_name: Gongjin-dan

object_name: dizziness chronic


subject: UMLS:C2986393

object_name: Locally Advanced Unresectable Uveal Melanoma


subject: UNII:NQ99E8OH3P

subject_name: Rilematovir

object_name: respiratory tract infectious disorder


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: colorectal cancer


subject: UNII:K16AIQ8CTM

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Epileptic seizures related to drugs


subject: UMLS:C3274552

object_name: neoplasm


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Acute Pain


subject: UNII:6PJC3KPK6S

object_name: cervical cancer


subject: UNII:6PJC3KPK6S

object_name: cervical carcinoma


subject: UNII:6PJC3KPK6S

object_name: endometrial cancer


subject: UNII:6PJC3KPK6S

object_name: uterine corpus cancer


subject: UNII:6PJC3KPK6S

object_name: endometrial carcinoma


subject: UNII:6PJC3KPK6S

object_name: ovarian cancer


subject: UNII:6PJC3KPK6S

object_name: ovarian neoplasm


subject: UNII:6PJC3KPK6S

object_name: ovarian carcinoma


subject: UNII:6PJC3KPK6S

object_name: Childhood Breast Carcinoma


subject: UNII:6PJC3KPK6S

object_name: breast carcinoma


subject: UNII:6PJC3KPK6S

object_name: breast cancer


subject: UMLS:C1541384

subject_name: TLR7 Agonist 852A


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: CHEBI:75179

subject_name: Trifluridine

object_name: bile duct carcinoma


subject: CHEBI:75179

object_name: bile duct cancer


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: PUBCHEM.COMPOUND:3379

subject_name: Nasalide

object_name: childhood onset asthma


subject: UMLS:C1569761

subject_name: flunisolide HFA


subject: CHEBI:5106

subject_name: Flunisolide


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:57986


subject: CHEBI:57986


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: type 2 diabetes mellitus


subject: CHEBI:22198

object_name: hypertension


subject: CHEBI:22198

object_name: Hypertension, CTCAE


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: UNII:5Y869C2THE

object_name: toothache


subject: MESH:C469818


subject: PR:000023026

subject_name: prophage integrase IntD

object_name: influenza


subject: UniProtKB:P62904

subject_name: TNR5_STRA5 Transposase from transposon Tn1545 (sprot)


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: hypersensitivity pneumonitis


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: neurofibroma


subject: UMLS:C1449662

subject_name: Levulan


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE

object_name: childhood optic nerve glioma


subject: UNII:807ME4B7IJ

object_name: optic pathway glioma


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: plasma cell myeloma


subject: CHEBI:72313

object_name: Relapse multiple myeloma


subject: CHEBI:72313

object_name: Plasma cell myeloma recurrent


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: PUBCHEM.COMPOUND:11332179


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: postpartum hemorrhage


subject: CHEBI:28787

object_name: Post-partum hemorrhage


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Cervix carcinoma recurrent


subject: CHEBI:79699

object_name: Cervical carcinoma stage IVB


subject: CHEBI:79699

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Cervical carcinoma stage IVA


subject: CHEBI:79699

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: CHEBI:79699

object_name: cervical squamous cell carcinoma


subject: CHEBI:79699

object_name: cervical adenosquamous carcinoma


subject: CHEBI:63633

subject_name: Triptorelin

object_name: prostate neoplasm


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: RENAL FAILURE CHRONIC REQUIRING HEMODIALYSIS


subject: CHEBI:144421

subject_name: ferric citrate


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:139350422

object_name: bone sarcoma


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Chemotherapy-induced nausea and vomiting


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: traumatic encephalopathy


subject: CHEBI:41879

object_name: traumatic brain injury


subject: CHEBI:41879

object_name: brain edema


subject: CHEBI:35341

subject_name: steroid

object_name: heart disorder


subject: CHEBI:35341

object_name: coronary aneurysm


subject: CHEBI:35341

object_name: cardiovascular disorder


subject: CHEBI:35341

object_name: Infection


subject: CHEBI:35341

object_name: infectious disease


subject: CHEBI:35341

object_name: Adverse Event Associated with Infection


subject: DRUGBANK:DB16436


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: cannabis abuse


subject: UNII:2N4O9L084N

object_name: post-traumatic stress disorder


subject: DRUGBANK:DB16541

subject_name: Lactobacillus casei

object_name: Exercise induced muscle damage


subject: DRUGBANK:DB16541

object_name: Delayed onset muscle pain


subject: GTOPDB:1786

subject_name: PTH

object_name: hyperparathyroidism


subject: GTOPDB:1786

object_name: Hyperparathyroidism, CTCAE


subject: GTOPDB:1786

object_name: humoral hypercalcemia of malignancy


subject: GTOPDB:1786

object_name: Bone Diseases, Endocrine


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone


subject: CHEBI:41879

object_name: Hashimoto thyroiditis


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Injury


subject: CHEBI:9316

object_name: Trauma


subject: UNII:YEI21W005Y

subject_name: Metformin glycinate

object_name: abdominal obesity-metabolic syndrome


subject: UNII:YEI21W005Y

object_name: metabolic syndrome X


subject: UNII:YEI21W005Y


subject: UMLS:C5418455

subject_name: Metformin Glycinate


subject: UMLS:C5418455


subject: UMLS:C5418455


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

object_name: cancer


subject: UMLS:C4019076

object_name: neoplasm


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: erythroleukemia


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: Sentinel node (disorder)


subject: UMLS:C1251704

object_name: Childhood Breast Carcinoma


subject: UMLS:C1251704

object_name: breast carcinoma


subject: UMLS:C1251704

object_name: breast cancer


subject: UMLS:C1251704

object_name: Malignant neoplasm of female breast


subject: UMLS:C1251704

object_name: breast neoplasm


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: leukemia


subject: CHEBI:100241

object_name: childhood leukemia


subject: CHEBI:100241

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:100241

object_name: acute myeloid leukemia


subject: CHEBI:2677

subject_name: Augmentin

object_name: Helicobacter pylori infection


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: CHEBI:81716

subject_name: Calcium propionate

object_name: type 2 diabetes mellitus


subject: CHEBI:81716

object_name: Insulin resistance


subject: CHEBI:81716

object_name: Diabetes


subject: CHEBI:81716

object_name: diabetes mellitus


subject: CHEBI:81716

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:81716

object_name: obesity


subject: CHEBI:81716

object_name: Obesity, CTCAE


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Neck Carcinoma


subject: CHEBI:9943

object_name: head and neck neoplasm


subject: CHEBI:9943

object_name: head and neck cancer


subject: CHEBI:62088

subject_name: Metamizole

object_name: stroke disorder


subject: CHEBI:62088

object_name: cerebrovascular disorder


subject: CHEBI:62088

object_name: Stroke (heart beat)


subject: CHEBI:62088

object_name: Stroke, CTCAE


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: heart failure


subject: CHEBI:17061

object_name: Heart Failure, CTCAE


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: B-cell neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: mantle cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: follicular lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: marginal zone lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594508

object_name: MALT lymphoma


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C4745143


subject: UMLS:C0242903

subject_name: Anesthetics, Inhalation

object_name: Inguinal hernia


subject: CHEBI:90881

subject_name: Camptosar

object_name: squamous cell carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:8884

subject_name: Rocuronium

object_name: organophosphate poisoning


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: glioma


subject: CHEBI:47519

object_name: malignant glioma


subject: CHEBI:47519

object_name: Recurrent Glioma


subject: CHEBI:47519

object_name: Metastatic Breast Carcinoma in the Brain


subject: CHEBI:47519

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:47519

object_name: invasive breast carcinoma


subject: CHEBI:47519

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:47519

object_name: adult oligodendroglioma


subject: CHEBI:47519

object_name: oligodendroglioma


subject: CHEBI:47519

object_name: childhood oligodendroglioma


subject: CHEBI:47519

object_name: Childhood Astrocytoma


subject: CHEBI:47519

object_name: astrocytic tumor


subject: CHEBI:47519

object_name: astrocytoma


subject: UMLS:C3274621

object_name: leukemia


subject: UMLS:C3274621

object_name: childhood leukemia


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:75045

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:233593

subject_name: Flumatinib

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:233593

object_name: BCR-ABL1 Fusion Protein Expression


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: intracerebral hemorrhage


subject: CHEBI:42446

subject_name: Esflurbiprofen

object_name: acute pharyngitis


subject: CHEBI:42446

object_name: Pharyngalgia


subject: CHEBI:42446

object_name: Sore Throat, CTCAE


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:5130


subject: CHEBI:5130


subject: CHEBI:6801

subject_name: Metformin

object_name: Her2-receptor negative breast cancer


subject: UNII:AJQ2ZNG2WL

subject_name: Myocet


subject: UMLS:C1512062


subject: CHEBI:81783

subject_name: Tricyclazole

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4521565

subject_name: Beam -- chemical


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Disorder of transplanted kidney


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: chronic kidney disease


subject: UMLS:C2984024

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:6897GXD6OE


subject: UNII:6897GXD6OE


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: UMLS:C0879578

object_name: colorectal cancer


subject: UMLS:C0879578

object_name: colorectal carcinoma


subject: UMLS:C0879578

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:72296

subject_name: Apixaban

object_name: heart valve disorder


subject: CHEBI:72296

object_name: cardiovascular disorder


subject: CHEBI:72296

object_name: heart disorder


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: aortic valve disease 2


subject: CHEBI:70746

object_name: aortic stenosis


subject: CHEBI:70746

object_name: aortic valve disease 3


subject: CHEBI:70746

object_name: Stenosis of aorta


subject: CHEBI:70746

object_name: aortic valve disorder


subject: CHEBI:70746


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: CHEBI:85974


subject: CHEBI:85974


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UMLS:C4224227

subject_name: Thrombi-Gel

object_name: lymphocele


subject: UMLS:C4224227

object_name: Lymphocele, CTCAE


subject: UMLS:C4224227

object_name: endometrial cancer


subject: UMLS:C4224227

object_name: endometrial carcinoma


subject: UMLS:C4224227

object_name: Lymphocele after surgical procedure


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Diabetes


subject: PUBCHEM.COMPOUND:18772499

object_name: diabetes mellitus


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UMLS:C3500981

object_name: type 2 diabetes mellitus


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Tremor


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:63633

subject_name: Triptorelin

object_name: Hodgkin Disease


subject: CHEBI:63633

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:63633

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4527156

object_name: colorectal cancer


subject: UMLS:C4527156

object_name: colorectal carcinoma


subject: UMLS:C4527156

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:4BBS3A53GJ

subject_name: calcium citrate malate

object_name: Adolescent Development


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cognitive disorder


subject: CHEBI:28939

object_name: negative type; schizophrenic


subject: CHEBI:31515

subject_name: Domperidone

object_name: Chronic idiopathic constipation


subject: CHEBI:31515

object_name: Vomiting, CTCAE


subject: CHEBI:31515

object_name: Vomiting


subject: CHEBI:31515

object_name: Nausea, CTCAE_5


subject: CHEBI:31515

object_name: Nausea


subject: CHEBI:31515

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Overweight and obesity


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:94534

subject_name: olanzapine

object_name: Cachexia


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Verruca plana


subject: CHEBI:131167

subject_name: Losmapimod

object_name: acute coronary syndrome


subject: UMLS:C3272847


subject: UMLS:C5447489

object_name: Solid Neoplasm


subject: CHEBI:231621

subject_name: Tasisulam

object_name: metastatic melanoma


subject: UMLS:C2353146

object_name: colorectal cancer


subject: UMLS:C2353146

object_name: colorectal carcinoma


subject: UMLS:C2353146

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Atrophic


subject: UMLS:C0592155

subject_name: Syntocinon


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: Benign thyroid nodule


subject: CHEBI:75551

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:75551

object_name: non-Hodgkin lymphoma


subject: CHEBI:75551

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:75551

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:75551

object_name: follicular lymphoma


subject: UMLS:C0556157

subject_name: Nutritional product supplementation

object_name: Muscle Atrophy


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:91414

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:91414

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:91414

object_name: Locally Advanced Clear Cell Renal Cell Carcinoma


subject: CHEBI:91414

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:91414

object_name: clear cell renal carcinoma


subject: CHEBI:91414

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:91414

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:FX3YKK43YM

subject_name: PACTIMIBE SULFATE

object_name: Familial hypercholesterolemia - heterozygous


subject: UNII:FX3YKK43YM

object_name: arteriosclerosis disorder


subject: UNII:FX3YKK43YM

object_name: atherosclerosis


subject: UNII:D874R9PZ9T

subject_name: Pactimibe


subject: UNII:D874R9PZ9T


subject: UNII:D874R9PZ9T


subject: UMLS:C1721398

subject_name: pactimibe sulfate


subject: UMLS:C1721398


subject: UMLS:C1721398


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: trichinellosis


subject: PUBCHEM.COMPOUND:9891967

object_name: Human Trichinellosis


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:104747

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:104747

object_name: head and neck cancer


subject: UMLS:C3827091

object_name: Chronic myeloid leukemia in remission


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: neurodegenerative disease


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:54675783

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:54675783

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: colon cancer


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:2735

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:2735

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:149509

object_name: cocaine dependence


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Advanced cancer


subject: UNII:H81695M5OP

subject_name: nattokinase

object_name: Cerebral Blood Flow


subject: UMLS:C0131956


subject: UMLS:C5854437

subject_name: XBH 25

object_name: endometrial cancer


subject: UMLS:C5854437

object_name: uterine corpus cancer


subject: UMLS:C5854437

object_name: endometrial carcinoma


subject: UMLS:C5854437

object_name: malignant testicular germ cell tumor


subject: UMLS:C5854437

object_name: neoplasm of testis


subject: UMLS:C5854437

object_name: testicular cancer


subject: UMLS:C5854437

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5854437

object_name: cholangiocarcinoma


subject: UMLS:C5854437

object_name: head and neck squamous cell carcinoma


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: glioblastoma


subject: CHEBI:7496

object_name: Childhood Glioblastoma


subject: CHEBI:7496

object_name: adult glioblastoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Intracranial glioma


subject: CHEBI:53074

subject_name: Diphencyprone

object_name: neoplasm


subject: CHEBI:34756

subject_name: fenamic acid


subject: PR:000006319

subject_name: m7GpppN-mRNA hydrolase


subject: UMLS:C5418090

subject_name: CDK4/6 Inhibitor CS3002

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C560745

object_name: major depressive disorder


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: rheumatoid arthritis


subject: UMLS:C5907942

subject_name: Pan-KRAS Inhibitor YL-17231


subject: UMLS:C4684973

subject_name: Hou Gu Mi Xi

object_name: Stomach cancer


subject: UMLS:C4684973

object_name: gastric cancer


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Brainstem death


subject: CHEBI:17650

object_name: Brain Death


subject: UMLS:C3490787

subject_name: BF-200 ALA

object_name: keratosis


subject: UMLS:C3490787

object_name: Keratoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Hyperprogression


subject: UMLS:C4053601


subject: CHEBI:90620

subject_name: Vatalanib

object_name: non-small cell lung carcinoma


subject: UMLS:C0912413

subject_name: PTK 787


subject: CHEBI:90623


subject: UMLS:C1524078


subject: PUBCHEM.COMPOUND:156071569

subject_name: silevertinib


subject: PUBCHEM.COMPOUND:156071569


subject: PUBCHEM.COMPOUND:156071569

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:156071569

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: PUBCHEM.COMPOUND:156071569

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:156071569

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: PUBCHEM.COMPOUND:156071569

object_name: EGFR-TKI Resistant Mutation


subject: PUBCHEM.COMPOUND:156071569

object_name: Advanced Lung Carcinoma


subject: UNII:RP9F537KVY

subject_name: SILEVERTINIB


subject: UNII:RP9F537KVY


subject: UNII:RP9F537KVY


subject: UNII:RP9F537KVY


subject: UNII:RP9F537KVY


subject: UNII:RP9F537KVY


subject: UNII:RP9F537KVY


subject: UNII:RP9F537KVY


subject: UMLS:C5706362

subject_name: Mutant-selective EGFR Inhibitor BDTX-1535


subject: UMLS:C5706362


subject: UMLS:C5706362


subject: UMLS:C5706362


subject: UMLS:C5706362


subject: UMLS:C5706362


subject: UMLS:C5706362


subject: UMLS:C5706362


subject: UNII:AH2E5UQ11Y

object_name: phobic disorder


subject: UNII:9HRI13ZIDX

subject_name: vanutide cridificar

object_name: Alzheimer disease


subject: UMLS:C4079610


subject: CHEBI:35186

subject_name: terpene

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:31684

subject_name: Ibudilast

object_name: glioblastoma


subject: CHEBI:31684

object_name: Childhood Glioblastoma


subject: CHEBI:31684

object_name: adult glioblastoma


subject: CHEBI:31684

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:31684

object_name: Recurrent Glioblastoma


subject: UMLS:C5700130


subject: UMLS:C5700130


subject: UMLS:C5700130


subject: UMLS:C5700130


subject: UMLS:C5700130


subject: UMLS:C5392435

subject_name: Adrecizumab


subject: UMLS:C5446738

subject_name: enibarcimab


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Complication of hemodialysis


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C1327750

subject_name: DCVax-L

object_name: ovarian cancer


subject: UMLS:C1327750

object_name: ovarian neoplasm


subject: UMLS:C1327750

object_name: ovarian carcinoma


subject: UMLS:C1327750

object_name: primary peritoneal carcinoma


subject: UMLS:C1327750

object_name: Primary Peritoneal Cancer


subject: CHEBI:6801

subject_name: Metformin

object_name: Non-genital warts NOS


subject: UMLS:C3896922

subject_name: GalNAc-siRNA Conjugate ALN-CC5

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:125427

object_name: prostate neoplasm


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:49828

subject_name: Praseodymium


subject: CHEBI:49828


subject: CHEBI:73645

subject_name: Pro-Arg


subject: CHEBI:73645


subject: CHEBI:8645

subject_name: purpurin


subject: CHEBI:8645


subject: CHEBI:26308

subject_name: propyl group


subject: CHEBI:26308


subject: PR:000016426

subject_name: voltage-dependent calcium channel gamma-like subunit


subject: PR:000016426


subject: UMLS:C0034833

subject_name: Receptors, Progesterone


subject: UMLS:C0034833


subject: PR:000012621

subject_name: progesterone receptor


subject: PR:000012621


subject: UMLS:C2365506

subject_name: PR Otic


subject: UMLS:C2365506


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Alzheimer disease type 1


subject: UNII:0K5743G68X

object_name: Alzheimer disease


subject: CHEBI:4910

subject_name: Etomidate

object_name: bile duct cyst


subject: CHEBI:4910

object_name: congenital hydronephrosis


subject: CHEBI:4910

object_name: Bone fracture


subject: CHEBI:4910

object_name: Fracture, CTCAE


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: secondary progressive multiple sclerosis


subject: UMLS:C5854402

subject_name: Anti-HER3 Antibody-drug Conjugate YL202

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854402

object_name: breast carcinoma


subject: UMLS:C5854402

object_name: breast cancer


subject: PUBCHEM.COMPOUND:5378597


subject: CHEBI:68352

subject_name: Isoquercetin


subject: CHEBI:63450

subject_name: Masitinib


subject: UMLS:C0962969

subject_name: RAD 001

object_name: PTEN hamartoma tumor syndrome


subject: UMLS:C0962969

object_name: PTEN gene mutation


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Central line-associated bloodstream infection


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Classical Hodgkin lymphoma refractory


subject: CHEBI:4026

object_name: Relapsing classical Hodgkin lymphoma


subject: CHEBI:4026

object_name: Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Mycosis fungoides refractory


subject: PUBCHEM.COMPOUND:3367

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: PUBCHEM.COMPOUND:3367

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Mycosis fungoides recurrent


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:135947

object_name: multiple sclerosis


subject: CHEBI:90936

subject_name: Alectinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:90936

object_name: breast carcinoma


subject: CHEBI:90936

object_name: breast cancer


subject: CHEBI:90936

object_name: digestive system cancer


subject: CHEBI:90936

object_name: Cancer Other


subject: CHEBI:231324

subject_name: alpelisib

object_name: non-small cell lung carcinoma


subject: CHEBI:231324


subject: CHEBI:231324


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: UNII:3DGD69C6PV

subject_name: brigatinib


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:114785

subject_name: Erlotinib


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:95089


subject: CHEBI:231679

subject_name: ipilimumab


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:19J3781LPM


subject: UNII:19J3781LPM


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: CHEBI:78543


subject: CHEBI:78543


subject: CHEBI:78543


subject: UNII:1WPE73O1WV

subject_name: PRALSETINIB


subject: UNII:1WPE73O1WV


subject: UNII:1WPE73O1WV


subject: UNII:1WPE73O1WV


subject: UNII:1WPE73O1WV


subject: CHEMBL.COMPOUND:CHEMBL4582651

subject_name: Pralsetinib


subject: CHEMBL.COMPOUND:CHEMBL4582651


subject: CHEMBL.COMPOUND:CHEMBL4582651


subject: CHEMBL.COMPOUND:CHEMBL4582651


subject: CHEMBL.COMPOUND:CHEMBL4582651


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: UNII:1IJV77EI07

subject_name: Tepotinib


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: septic shock


subject: CHEBI:3732

object_name: Severe Sepsis


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: heart failure


subject: CHEBI:75832

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: bone marrow failure syndrome


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Burn injury


subject: CHEBI:167574

subject_name: Semaglutide

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:166168413

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:166168413

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:166168413

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:166168413

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: PUBCHEM.COMPOUND:166168413

object_name: ataxia telangiectasia


subject: PUBCHEM.COMPOUND:166168413

object_name: melanoma


subject: PUBCHEM.COMPOUND:166168413


subject: UMLS:C5854403

subject_name: BRAF V600E Degrader CFT1946


subject: UMLS:C5854403


subject: UMLS:C5854403


subject: UMLS:C5854403


subject: UMLS:C5854403


subject: UMLS:C5854403


subject: UMLS:C5854403


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:16118

subject_name: Berberine

object_name: cirrhosis due to hepatitis C


subject: CHEBI:16118

object_name: cirrhosis due to hepatitis B


subject: CHEBI:16118

object_name: Gastroesophageal varices


subject: UMLS:C5783891

object_name: Childhood Breast Carcinoma


subject: UMLS:C5783891

object_name: breast carcinoma


subject: UMLS:C5783891

object_name: breast cancer


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Kaposi Sarcoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: CHEBI:10110

subject_name: Zidovudine


subject: UMLS:C5449291

subject_name: soybean, fermented

object_name: Heartburn


subject: CHEBI:83766

subject_name: Olaparib

object_name: renal cell adenocarcinoma


subject: CHEBI:83766

object_name: renal cell carcinoma


subject: CHEBI:83766

object_name: thyroid gland carcinoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:71219

subject_name: Pazopanib

object_name: endometrial carcinoma


subject: UMLS:C5556341

subject_name: MAT2A Inhibitor IDE397

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556341

object_name: Adult Solid Neoplasm


subject: UMLS:C5556341

object_name: Solid Neoplasm


subject: CHEBI:94463

object_name: hemolytic anemia


subject: CHEBI:94463

object_name: non-autoimmune hemolytic anemia


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: UMLS:C2934792

object_name: influenza


subject: CHEBI:9123

subject_name: Sertraline

object_name: premenstrual tension


subject: CHEBI:9123

object_name: polydactyly-myopia syndrome


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Relapsing acute myeloid leukemia


subject: GTOPDB:9615

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:84036

subject_name: Aldoxorubicin


subject: UMLS:C4722367


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: UNII:B0L24T8TB7


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C4552849

subject_name: haNK


subject: CHEBI:15372

object_name: Rheumatism


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:37924

subject_name: Atazanavir

object_name: hyperlipidemia


subject: CHEBI:37924

object_name: hyperlipoproteinemia


subject: CHEBI:37924

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:37924

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: brain neoplasm


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA

object_name: ventilator-associated pneumonia


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: Childhood Solid Neoplasm


subject: UMLS:C0596581

object_name: Adult Solid Neoplasm


subject: UMLS:C0596581

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Xerostomia


subject: CHEBI:90227

subject_name: Selumetinib

object_name: uveal melanoma


subject: CHEBI:75551


subject: CHEBI:145304

subject_name: monoacylglycerol 22:5


subject: CHEBI:94793

subject_name: Pimasertib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:94793

object_name: Childhood Breast Carcinoma


subject: CHEBI:94793

object_name: breast carcinoma


subject: CHEBI:94793

object_name: breast cancer


subject: UMLS:C3642441

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C3642441


subject: UMLS:C3642441

object_name: colorectal cancer


subject: UMLS:C3642441

object_name: colorectal carcinoma


subject: UMLS:C3642441

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3642441

object_name: non-small cell lung carcinoma


subject: UMLS:C3642441


subject: UMLS:C3642441


subject: UMLS:C3642441


subject: UMLS:C3642441

object_name: melanoma


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C0044602

subject_name: 1-Phosphatidylinositol 3-Kinase


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: UMLS:C0044602


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778


subject: CHEBI:68481

subject_name: mTOR inhibitor


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: CHEBI:68481


subject: UMLS:C2746052

subject_name: MTOR Inhibitors


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: HIV infection


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:90881

subject_name: Camptosar

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:90881

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:90881

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:9908

subject_name: Ursolic acid

object_name: prostate carcinoma


subject: CHEBI:9908

object_name: prostate cancer


subject: CHEBI:39867

object_name: acute graft versus host disease


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: coccidioidomycosis


subject: PR:000015526

subject_name: transcription factor Spi-C

object_name: Facial edema


subject: PR:000015526

object_name: Facial swelling (finding)


subject: PR:000015526

object_name: Displaced tooth


subject: PR:000015526

object_name: Tooth avulsion


subject: PR:000015526

object_name: Impacted tooth


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: UMLS:C0033374


subject: UMLS:C0033374


subject: UMLS:C0033374


subject: UMLS:C0033374


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: Headache


subject: CHEBI:51209

object_name: Headache, CTCAE


subject: CHEBI:51209

object_name: Nasal Congestion, CTCAE


subject: CHEBI:51209

object_name: Nasal congestion


subject: UNII:SH2RFM47U8

object_name: diabetes mellitus


subject: UNII:SH2RFM47U8

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:SH2RFM47U8

object_name: obesity


subject: UNII:SH2RFM47U8

object_name: Obesity, CTCAE


subject: UMLS:C5417855

subject_name: IRDye800-labeled Heterodimeric Peptide KSP-QRH 919288G

object_name: Well adult


subject: PUBCHEM.COMPOUND:16208013

subject_name: Tecemotide

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:16208013

object_name: prostate cancer


subject: UNII:Q7Y026G2CX

subject_name: TECEMOTIDE


subject: UNII:Q7Y026G2CX


subject: UMLS:C1832016


subject: UMLS:C1832016


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: kidney failure


subject: PUBCHEM.COMPOUND:122527270

subject_name: bemnifosbuvir


subject: PUBCHEM.COMPOUND:122527270

object_name: Hepatic impairment


subject: UNII:7UM3SQL968


subject: UNII:7UM3SQL968


subject: DRUGBANK:DB19050

subject_name: Bemnifosbuvir


subject: DRUGBANK:DB19050


subject: PUBCHEM.COMPOUND:127021097

subject_name: RUZASVIR


subject: PUBCHEM.COMPOUND:127021097


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Light for dates


subject: CHEBI:73604

object_name: anemia of prematurity


subject: CHEBI:70839

subject_name: Dasatinib

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:70839

object_name: chronic myelomonocytic leukemia


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib


subject: PUBCHEM.COMPOUND:11654566


subject: PUBCHEM.COMPOUND:11654566

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:231350

subject_name: Pacritinib

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:231350

object_name: Refractory acute myeloid leukemia


subject: CHEBI:231350

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:231350

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:231350


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: CHEBI:78543


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Acute Ischemic Stroke


subject: CHEBI:74947

subject_name: Thalidomide

object_name: carcinoma of esophagus


subject: CHEBI:167308

subject_name: Dextromethadone

object_name: Restless legs


subject: MESH:C000626862

subject_name: D-methadone


subject: UMLS:C5564654


subject: GTOPDB:3589

subject_name: adrenomedullin

object_name: CADASIL


subject: GTOPDB:3589

object_name: CADASIL 1


subject: UNII:QA0A21Y20D

subject_name: ADRENOMEDULLIN


subject: UNII:QA0A21Y20D


subject: UMLS:C0215825


subject: UMLS:C0215825


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: mood (physical finding)


subject: UNII:71M78END5S

object_name: Depressive Symptoms


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Stage II Prostate Cancer AJCC v6


subject: UMLS:C1882421

object_name: Stage II Prostate Cancer AJCC v8


subject: UMLS:C1882421

object_name: Carcinoma of the prostate stage II


subject: UMLS:C1882421

object_name: Stage II Prostate Cancer AJCC v7


subject: UMLS:C1882421

object_name: prostate adenocarcinoma


subject: UMLS:C5782768

subject_name: BUPivacaine 0.25% injectable solution

object_name: pain agnosia


subject: UMLS:C5782768

object_name: Pain insensitivity


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Multiple Trauma


subject: UMLS:C5666918

subject_name: Lancastotug

object_name: liver carcinoma


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:77562

object_name: lung large cell carcinoma


subject: CHEBI:77562

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:50217

subject_name: selegiline

object_name: endogenous depression


subject: UMLS:C1529682

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C1529682

object_name: skin melanoma


subject: UMLS:C1529682

object_name: malignant soft tissue neoplasm


subject: UMLS:C1529682

object_name: sarcoma


subject: PUBCHEM.COMPOUND:2269

object_name: Compulsion


subject: PUBCHEM.COMPOUND:2269

object_name: Pediatric acute-onset neuropsychiatric syndrome


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Mitochondrial alteration


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: peritoneum cancer


subject: CHEBI:4974

subject_name: Famciclovir

object_name: multiple sclerosis


subject: UMLS:C1260201

subject_name: AMG 073

object_name: tumor of parathyroid gland


subject: CHEBI:48390

subject_name: Cinacalcet


subject: UMLS:C0003241

subject_name: Antibodies

object_name: EXCESS LMW-DNA


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: UMLS:C5667022

subject_name: Anti-LILRB2 Monoclonal Antibody IO-108

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:77562

object_name: Non-small cell lung cancer stage III


subject: CHEBI:77562

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:64310


subject: CHEBI:64310


subject: UMLS:C1705207

subject_name: Endostar

object_name: radiation pneumonitis


subject: CHEBI:95341

subject_name: Baricitinib

object_name: mucous membrane pemphigoid


subject: CHEBI:95341

object_name: Cicatrizing conjunctivitis


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: sickle cell disease


subject: CHEBI:57694

object_name: cesarean section; complications


subject: CHEBI:57694

object_name: Post-Operative Pain


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate

object_name: mental disorder


subject: PUBCHEM.COMPOUND:23279496

object_name: Atypical behavior


subject: CHEBI:23503

subject_name: DL-Cycloserine

object_name: drug dependence


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:169833

subject_name: Deacetyldiltiazem


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:6073

subject_name: Isradipine


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Oligometastasis


subject: CHEBI:31355

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:90929

subject_name: Lesinurad

object_name: chronic kidney disease


subject: CHEBI:191043

object_name: Inflammatory pain


subject: UMLS:C1958118


subject: UMLS:C3641177

subject_name: PEG-3350/Sodium Sulfate/Sodium Chloride/Potassium Chloride/Sodium Ascorbate/Ascorbic Acid-based Laxative

object_name: colon adenoma


subject: UNII:2WQX2MS3MQ

object_name: psoriasis


subject: UNII:2WQX2MS3MQ


subject: UNII:2WQX2MS3MQ

object_name: ankylosing spondylitis


subject: UNII:2WQX2MS3MQ

object_name: inflammatory bowel disease


subject: UNII:2WQX2MS3MQ

object_name: rheumatoid arthritis


subject: DRUGBANK:DB19007


subject: DRUGBANK:DB19007


subject: DRUGBANK:DB19007


subject: DRUGBANK:DB19007


subject: DRUGBANK:DB19007


subject: UMLS:C3491843

object_name: Leigh syndrome


subject: PUBCHEM.COMPOUND:14586216

subject_name: Prunus inhibitor b

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:14586216

object_name: Alzheimer disease


subject: CHEBI:53725

subject_name: poly(isobutylene)


subject: CHEBI:53725


subject: UMLS:C4764404

subject_name: Recombinant human glutamic acid decarboxylase

object_name: type 1 diabetes mellitus 1


subject: UMLS:C4764404

object_name: type 1 diabetes mellitus


subject: UMLS:C0935952

subject_name: Oncophage

object_name: renal carcinoma


subject: UMLS:C0935952

object_name: kidney neoplasm


subject: UMLS:C0935952

object_name: kidney cancer


subject: CHEBI:64816

object_name: adenoid cystic carcinoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:52717

subject_name: Bortezomib

object_name: adrenal cortex carcinoma


subject: CHEBI:52717


subject: UMLS:C3827119

subject_name: Recombinant Human Adenovirus Type 5 H101

object_name: Advanced Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: Nocturia


subject: CHEBI:23359

subject_name: colchicine

object_name: MYOCARDIAL INFARCTION PERIOPERATIVE


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Eosinophilic infiltration of the esophagus


subject: UNII:90Z2UF0E52

object_name: eosinophilic gastroenteritis


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: acne


subject: CHEBI:177650

subject_name: Mapracorat

object_name: atopic eczema


subject: CHEBI:177650

object_name: dermatitis


subject: CHEBI:177650

object_name: Eczema, CTCAE


subject: PUBCHEM.COMPOUND:56843465

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:56843465

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:56843465

object_name: prostate cancer


subject: CHEBI:95061


subject: CHEBI:95061


subject: CHEBI:95061


subject: CHEBI:45409

subject_name: Ritonavir

object_name: COVID-19 respiratory infection


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Depression in old age


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:149509

object_name: migraine with aura


subject: CHEBI:149509

object_name: Transformed migraine


subject: CHEBI:149509

object_name: Common Migraine


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: UMLS:C3535837

subject_name: caseinate

object_name: chronic obstructive pulmonary disease


subject: UMLS:C2756587

subject_name: soy


subject: UMLS:C1697820

subject_name: soy - non-drug agent


subject: UMLS:C1883555

subject_name: Whey Protein Isolate


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain


subject: CHEBI:80271

subject_name: Glp-2 [MI]

object_name: type 2 diabetes mellitus


subject: UMLS:C0912332

subject_name: Glucagon-Like Peptide 2


subject: CHEBI:50992

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:50992

object_name: obesity


subject: CHEBI:50992

object_name: Obesity, CTCAE


subject: CHEBI:50992

object_name: Insulin resistance


subject: CHEBI:50992

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:50992

object_name: metabolic syndrome X


subject: UMLS:C3537039

subject_name: Thiazolidinedione [EPC]


subject: UMLS:C3537039


subject: UMLS:C3537039


subject: UMLS:C3537039


subject: UMLS:C3537039


subject: UMLS:C3537039


subject: CHEBI:50990

subject_name: thiazolidinediones


subject: CHEBI:50990


subject: CHEBI:50990


subject: CHEBI:50990


subject: CHEBI:50990


subject: UMLS:C0751598

subject_name: Alferon

object_name: carcinoma of urethra


subject: UMLS:C0751598

object_name: urethra cancer


subject: UMLS:C0751598

object_name: bladder tumor


subject: UMLS:C0751598

object_name: urinary bladder carcinoma


subject: UMLS:C0751598

object_name: urinary bladder cancer


subject: UMLS:C0751598

object_name: childhood bladder carcinoma


subject: CHEBI:32599

object_name: sickle cell disease


subject: UMLS:C1328695

subject_name: silicon phthalocyanine 4

object_name: Cutaneous T-cell lymphoma stage I


subject: UMLS:C1328695

object_name: Cutaneous T-cell lymphoma stage II


subject: UMLS:C1328695

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1328695

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C1328695

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1328695

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1328695

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C1328695

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:KUW1QG1ZM3

subject_name: siplizumab

object_name: Acne inversa


subject: UMLS:C1310928


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:6887

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:6887

object_name: morbid obesity


subject: CHEBI:16866

subject_name: alizarin

object_name: malaria


subject: UNII:4NJ842U6BZ

subject_name: azimexon


subject: PR:000022182

subject_name: regulatory protein AtoC


subject: DRUGBANK:DB19246

subject_name: Bacillus coagulans

object_name: acute graft versus host disease


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: blepharospasm


subject: UNII:UC95NQ339C

object_name: Epiphora


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: PUBCHEM.COMPOUND:11300448

subject_name: axomadol

object_name: Chronic low back pain


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: osteoporosis


subject: UMLS:C0013227

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C0013227

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C0013227

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Anastomotic complication


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: open-angle glaucoma


subject: UMLS:C1517132

subject_name: Farnesyl Transferase Inhibitor

object_name: plasma cell myeloma


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Early Stage Breast Carcinoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: Nasal Polyp


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: laceration of skin (physical finding)


subject: UMLS:C2346514

object_name: Skin laceration


subject: UMLS:C2346514

object_name: anxiety


subject: UMLS:C2346514

object_name: anxiety disorder


subject: UMLS:C2346514

object_name: Anxiety symptoms


subject: UMLS:C2346514

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C2346514

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Episodic migraine


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:91899

object_name: rhinitis


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEMBL.COMPOUND:CHEMBL4650390

subject_name: DESCARTES 30

object_name: acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL4650390

object_name: adult acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL4650390


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: esophagitis


subject: CHEBI:50275

object_name: Esophagitis, CTCAE


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium

object_name: Reflux


subject: PUBCHEM.COMPOUND:118987284

object_name: Barrett esophagus


subject: PUBCHEM.COMPOUND:118987284


subject: PUBCHEM.COMPOUND:118987284


subject: UNII:OEP8JJ3OZR

subject_name: Nemiralisib

object_name: immunodeficiency 14


subject: UNII:OEP8JJ3OZR

object_name: activated PI3K-delta syndrome


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Neck pain


subject: CHEBI:2666

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:2666

object_name: Neck Pain, CTCAE 3.0


subject: PUBCHEM.COMPOUND:73049652

subject_name: Gadofosveset Trisodium

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:73049652

object_name: peripheral arterial disease


subject: PUBCHEM.COMPOUND:73049652

object_name: intermittent vascular claudication


subject: PUBCHEM.COMPOUND:73049652

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:73049652

object_name: atherosclerosis


subject: UNII:9430ZR8ZAN

subject_name: gadofosveset


subject: UNII:9430ZR8ZAN


subject: UNII:9430ZR8ZAN


subject: UNII:9430ZR8ZAN


subject: UNII:9430ZR8ZAN


subject: UMLS:C4528574

subject_name: PTPN11 inhibitor TNO155

object_name: Hepatic impairment


subject: CHEBI:6123

subject_name: Ketanserin

object_name: Severe Sepsis


subject: CHEBI:6123

object_name: septic shock


subject: CHEBI:114785

subject_name: Erlotinib

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:114785

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:114785

object_name: periampullary adenocarcinoma


subject: CHEBI:114785

object_name: small intestine cancer


subject: CHEBI:114785

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Arachnophobia


subject: CHEBI:17650

object_name: Fear of spiders


subject: CHEBI:58097

object_name: acute stress disorder


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: Cat Allergy


subject: UMLS:C0910794


subject: PUBCHEM.COMPOUND:26945

subject_name: Aqua-cem

object_name: variegate porphyria


subject: PUBCHEM.COMPOUND:26945

object_name: hereditary coproporphyria


subject: CHEBI:4445

subject_name: Desflurane

object_name: Postoperative Nausea


subject: CHEBI:73895

subject_name: Gly-D-Ser

object_name: pancreatic adenocarcinoma


subject: CHEBI:73516

subject_name: Gly-Ser


subject: PR:000008058

subject_name: glutamine synthetase


subject: CHEBI:6504

object_name: treatment resistant depression


subject: CHEBI:6504


subject: CHEBI:6504

object_name: endogenous depression


subject: CHEBI:6504

object_name: major depressive disorder


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor


subject: CHEBI:50949


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C0360105


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943


subject: UNII:ZE94SP78UG

object_name: acute myeloid leukemia by FAB classification


subject: UNII:ZE94SP78UG

object_name: acute myeloid leukemia


subject: UNII:ZE94SP78UG

object_name: juvenile myelomonocytic leukemia


subject: UNII:ZE94SP78UG

object_name: chronic myelomonocytic leukemia


subject: UNII:ZE94SP78UG

object_name: Myelodysplasia


subject: CHEBI:8378

subject_name: Prednisolone


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Disorder related to renal transplantation


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:95165

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:95165

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:95165

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:16335

subject_name: Adenosine

object_name: Decreased vascular flow


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: coronary microvascular disorder


subject: UNII:2XLN4Y044H


subject: UNII:2XLN4Y044H

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:2XLN4Y044H

object_name: obesity


subject: UNII:2XLN4Y044H

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: adult liposarcoma


subject: CHEBI:68646

object_name: liposarcoma


subject: CHEBI:68646

object_name: pediatric liposarcoma


subject: CHEBI:68646

object_name: mesenchymal chondrosarcoma


subject: CHEBI:68646

object_name: pediatric mesenchymal chondrosarcoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: UMLS:C1831909

subject_name: Cantuzumab ravtansine

object_name: gastric neoplasm


subject: UMLS:C1875784

subject_name: STEP 2

object_name: influenza


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: Pleural effusion


subject: UNII:WGD229O42W

object_name: Pleural Effusion, CTCAE


subject: UNII:WGD229O42W

object_name: x-ray of chest: pleural effusion


subject: UMLS:C5206815

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: primary pulmonary hypertension


subject: UMLS:C1521807

object_name: lung cancer


subject: UMLS:C1521807

object_name: lung neoplasm


subject: UMLS:C1521807

object_name: lung carcinoma


subject: UMLS:C4724855

subject_name: BCD 100

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4724855

object_name: clear cell renal carcinoma


subject: UMLS:C4724855

object_name: renal cell adenocarcinoma


subject: UMLS:C4724855

object_name: renal cell carcinoma


subject: UMLS:C4724855


subject: UMLS:C4724855


subject: UMLS:C4724855


subject: CHEBI:231353

subject_name: Orteronel

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:231353

object_name: Prostate cancer recurrent


subject: CHEBI:231353

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:231353

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:231353

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:231353

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:231353

object_name: prostate adenocarcinoma


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: colorectal cancer


subject: CHEBI:28787

object_name: colorectal carcinoma


subject: CHEBI:28787

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:28787

object_name: colorectal neoplasm


subject: CHEBI:28787

object_name: adenomatous colon polyp


subject: CHEBI:75958

subject_name: solution

object_name: anserine bursitis


subject: UMLS:C0037633

subject_name: Solutions


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: benign prostatic hyperplasia


subject: PUBCHEM.COMPOUND:5748345

subject_name: ANGIOTENSIN-II

object_name: Vasodilatory shock


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Geographic atrophy


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: CHEBI:52970

object_name: Chronic fatigue


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: UNII:305EB53128

subject_name: Dotinurad

object_name: Hyperuricemia


subject: UNII:305EB53128

object_name: Hyperuricemia, CTCAE


subject: GTOPDB:13615

subject_name: nedosiran

object_name: Hyperoxaluria


subject: GTOPDB:13615

object_name: primary hyperoxaluria type 1


subject: GTOPDB:13615

object_name: primary hyperoxaluria type 3


subject: GTOPDB:13615

object_name: primary hyperoxaluria type 2


subject: CHEMBL.COMPOUND:CHEMBL4650244

subject_name: NEDOSIRAN


subject: CHEMBL.COMPOUND:CHEMBL4650244


subject: CHEMBL.COMPOUND:CHEMBL4650244


subject: CHEMBL.COMPOUND:CHEMBL4650244


subject: CHEBI:144431

subject_name: montbretin A(1-)

object_name: type 2 diabetes mellitus


subject: CHEBI:144419

subject_name: montbretin A


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: PD-L1 Overexpression


subject: UMLS:C5434105

object_name: PD-L1 Positive


subject: CHEBI:2569

subject_name: Alfentanil

object_name: Dysesthesia


subject: UNII:9A54BAZ0YA

object_name: Multiple sclerosis relapse


subject: UMLS:C3713697


subject: UMLS:C0004886

subject_name: BCG Vaccine

object_name: fibromyalgia


subject: CHEBI:64312

subject_name: Memantine

object_name: Gait Disorders, Neurologic


subject: CHEBI:231425

subject_name: tolvaptan

object_name: heart disorder


subject: CHEBI:231425

object_name: cardiovascular disorder


subject: UMLS:C0678204

subject_name: Diamicron


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: gastric intestinal metaplasia


subject: UMLS:C2954629

subject_name: Systane Balance

object_name: Posterior blepharitis


subject: CHEBI:17553

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:17553

object_name: amyotrophic lateral sclerosis


subject: CHEBI:71464

subject_name: Palmidrol


subject: CHEBI:71464


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: UMLS:C1572795


subject: CHEBI:18397

subject_name: Phenethylamine


subject: CHEBI:18397


subject: DRUGBANK:DB10551

subject_name: Pea


subject: DRUGBANK:DB10551


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: Congenital defects


subject: UMLS:C2240391

object_name: Fetal anomaly


subject: UMLS:C2240391

object_name: reported family history of birth defects (history)


subject: UMLS:C2240391

object_name: Pregnant


subject: CHEBI:3223

subject_name: Buspirone

object_name: gastroparesis


subject: CHEBI:3223

object_name: Gastroparesis, CTCAE


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:77260

subject_name: Omeprazole

object_name: chronic rhinosinusitis


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Infection


subject: PUBCHEM.COMPOUND:147912

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:147912

object_name: Job Syndrome


subject: UMLS:C1725733

subject_name: ACB (Acebutolol)

object_name: opioid use


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Abnormal uterine bleeding unrelated to menstrual cycle


subject: CHEBI:30879

subject_name: alcohol

object_name: hepatitis C


subject: CHEBI:30879

object_name: HIV infection


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: osteoarthritis


subject: UMLS:C0592050

subject_name: Andriol

object_name: hypogonadism


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Stage I Lung Cancer AJCC v8


subject: UMLS:C2346492

object_name: non-small cell lung carcinoma


subject: UMLS:C2346492

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C0356365

subject_name: Insulin, Short-Acting

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0356365

object_name: type 1 diabetes mellitus


subject: CHEBI:94409

subject_name: Mitoglitazone

object_name: type 2 diabetes mellitus


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:5778

object_name: Acute heart failure


subject: CHEBI:5778

object_name: acute kidney failure


subject: CHEBI:5778

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:87681

subject_name: Ranolazine

object_name: heart disorder


subject: CHEBI:63660

object_name: adult lymphoma


subject: CHEBI:63660

object_name: lymphoma


subject: CHEBI:63660

object_name: pediatric lymphoma


subject: CHEBI:63660

object_name: malignant soft tissue neoplasm


subject: CHEBI:63660

object_name: sarcoma


subject: CHEBI:63660

object_name: breast carcinoma


subject: CHEBI:63660

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:63660

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:135193

subject_name: Fospropofol

object_name: interstitial cystitis


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)


subject: CHEBI:7507

subject_name: Framycetin

object_name: neoplasm


subject: CHEBI:131854

subject_name: Fotemustine

object_name: metastatic melanoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Myocardial fibrosis


subject: CHEBI:6801

object_name: congenital plasminogen activator inhibitor type 1 deficiency


subject: PR:000016622

subject_name: tRNA (cytosine-5-)-methyltransferase

object_name: Clostridium difficile colitis


subject: PR:000016622

object_name: clostridium difficile infection


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: H.pylori gastrointestinal disease


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:9144

subject_name: Silibinin

object_name: acute hepatitis C virus infection


subject: CHEBI:9144

object_name: acute hepatitis B virus infection


subject: CHEBI:9144

object_name: Acute Hepatitis E Infection


subject: CHEBI:9144

object_name: viral hepatitis E infection


subject: CHEBI:9144

object_name: hepatitis A


subject: CHEBI:9144

object_name: Acute type A viral hepatitis


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:125451


subject: CHEBI:125451


subject: CHEBI:125451


subject: CHEBI:125451


subject: CHEBI:8364

subject_name: Prazosin

object_name: Rhinitis medicamentosa


subject: CHEBI:8364

object_name: Atopic rhinitis


subject: CHEBI:8364

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: complete trisomy 21


subject: UMLS:C3714803

object_name: Down syndrome


subject: UMLS:C3714803

object_name: Alzheimer disease type 1


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Kaposi Sarcoma


subject: MESH:C576360

object_name: diabetic macular edema


subject: MESH:C576360

object_name: diabetic retinopathy


subject: MESH:C576360

object_name: choroidal neovascularization


subject: MESH:C576360

object_name: choroidal neovascularization (physical finding)


subject: CHEBI:6931

subject_name: Midazolam

object_name: morbid obesity


subject: DRUGBANK:DB17481


subject: CHEBI:45783

subject_name: Imatinib

object_name: ALK-positive anaplastic large cell lymphoma


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Myelodysplasia


subject: UMLS:C1832035


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:135659064

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: breast cancer


subject: PUBCHEM.COMPOUND:135659064

object_name: melanoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:71219

subject_name: Pazopanib

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3989992

subject_name: PEGILODECAKIN

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL3989992

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3989992

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: CHEMBL.COMPOUND:CHEMBL3989992


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UNII:28X28X9OKV

object_name: Vulval cancer metastatic


subject: UNII:28X28X9OKV

object_name: Stage IVB Vaginal Cancer AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Endometrial neoplasm malignant metastatic


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073